Pharmacodynamic studies of erlotinib in tumor and skin tissue samples of patients (Pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

Authors

Agulnik M; da Cunha-Santos G; Hedley D; Nicklee T; dos Reis PP; Ho J; Pond GR; Winquist E; Soulieres D; Chen EX

pp. 9071S-9071S

AMER ASSOC CANCER RESEARCH

December 15, 2005

AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics

Philadelphia, PA

November 14, 2005

November 18, 2005

CLINICAL CANCER RESEARCH

1078-0432

Gregory Pond